Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2001 Apr;158(4):1423–1432. doi: 10.1016/S0002-9440(10)64093-X

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2001, American Society for Investigative Pathology

PMC Copyright notice

Figure 3. — Inhibitory effects of Axl-Fc on Thy1 GN. Effects of Axl-Fc treatment on glomerular cell proliferation (A) and expression of OX-7 (B). A representative glomerulus at day 8 of Thy1 GN is shown. a, control; b, treatment with Fc; c, treatment with Axl-Fc in A and B. A: PAS staining. B: Immunofluorescent staining for OX-7. Original magnification, ×200. C: The number of PCNA-positive cells per glomeruli. PCNA-positive cell numbers per glomerular cross-section are counted as described in Materials and Methods. Open bar, control rats (day 0); closed bar, nontreated Thy1 rats; double-hatched bar, Thy1 rats treated with Fc; shaded bar, Thy1 rats treated with Axl-Fc in C and D. *, P < 0.001 versus nontreated Thy1 rats. D: Urinary albumin excretion standardized by urinary creatinine of Thy1 rats at day 8. *, P < 0.001 versus nontreated Thy1 rats.